Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

MNTL

Tema Neuroscience and Mental Health ETF

Last Close
Apr 11 04:00PM ET
25.10
Dollar change
+0.01
Percentage change
0.05
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) Tags- Return% 1Y- Shs Outstand Perf Week-0.11%
SponsorTema ETF Type Tags- Return% 3Y- Total Holdings46 Perf Month-4.18%
Fund Family Bond Type Tags- Return% 5Y- AUM11.01M Perf Quarter-
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range25.09 - 26.74 Perf YTD-1.53%
Dividend TTM- ESG Type Tags- Flows% 3M3091.51% 52W High-6.12% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD3091.51% 52W Low0.05% ATR (14)0.25
Expense0.75% Structure Type Region Flows% 1Y RSI (14)41.26 Volatility0.10% 0.21%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.04 Prev Close25.09
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume7.97K Price25.10
SMA20-1.97% SMA50-2.45% SMA200-2.40% Trades Volume310 Change0.05%
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.